Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Mark Pomeranz | President and COO, Director | $133K | Feb 10, 2022 | ||
Andrew Taylor | Chief Financial Officer | $118K | Feb 10, 2022 | ||
Gary J. Pruden | Director | Mar 5, 2024 | |||
Darren Sherman | Director | Feb 10, 2022 | |||
Shervin J. Korangy | Director | Feb 10, 2022 | |||
Orchestra BioMed Holdings, Inc. | 10%+ Owner | Sep 12, 2023 | |||
Sonja Nelson | Director | Mar 5, 2024 | |||
Timothy P. Moran | Director | Mar 5, 2024 | |||
Elad Amor | Chief Accounting Officer | Jun 2, 2023 | |||
David P. Hochman | Director, Chairman of the Board | Feb 10, 2022 | |||
Ravit Ram | Chief Financial Officer | Jun 2, 2023 | |||
Scott Durbin | Director | Mar 5, 2024 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|